# Chemotherapy and Radiotherapy for Osteolymphoma

> **NCT00141648** · NA · COMPLETED · sponsor: **Trans Tasman Radiation Oncology Group** · enrollment: 70 (actual)

## Conditions studied

- Osteolymphoma

## Interventions

- **DRUG:** Cyclophosphamide, Doxorubicin, Vincristine, Prednisolone.
- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT00141648
- **Lead sponsor:** Trans Tasman Radiation Oncology Group
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-09
- **Primary completion:** 2007-02
- **Final completion:** 2008-02
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2009-10-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00141648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00141648, "Chemotherapy and Radiotherapy for Osteolymphoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00141648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*